Live feed11:28:12·18mANALYSTRatingvia QuantisnowLeerink Partners resumed coverage on PTC Therapeutics with a new price targetByQuantisnow·Wall Street's wire, on your screen.PTCT· PTC Therapeutics Inc.Health CareOriginal source